China Sxt Pharmaceuticals Inc
(SXTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2018 | 03-2017 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 658 | 60 |
| Receivables | 2,736 | 3,760 |
| Inventories | 1,267 | 890 |
| Other current assets | 1,441 | 190 |
| TOTAL | $6,102 | $4,900 |
| Non-Current Assets | ||
| PPE Net | 1,462 | 910 |
| Other Non-Current Assets | 66 | 40 |
| TOTAL | $1,528 | $950 |
| Total Assets | $7,658 | $5,430 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 0 | 300 |
| Accounts payable and accrued liabilities | 2,400 | 1,260 |
| Accrued Expenses | 410 | 570 |
| Other current liabilities | 290 | 1,140 |
| TOTAL | $4,372 | $3,570 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $4,372 | $3,570 |
| Shareholders' Equity | ||
| Common Shares | 20 | 20 |
| Retained earnings | 1,545 | 350 |
| Other shareholders' equity | 261 | 20 |
| TOTAL | $3,286 | $1,850 |
| Total Liabilities And Equity | $7,658 | $5,420 |